Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

4.01
Delayed Data
As of Mar 24
 -0.17 / -4.07%
Today’s Change
2.51
Today|||52-Week Range
12.66
+8.97%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close4.18
Today’s open4.21
Day’s range3.95 - 4.21
Volume128,652
Average volume (3 months)143,701
Market cap$74.6M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+6.31%
Earnings growth (this year)+2.40%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.15+12.00%
FLKSFlex Pharma Inc-0.05-1.23%
CAPRCapricor Therapeutic...+0.16+4.98%
ORMPOramed Pharmaceutica...-0.06-1.01%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$19.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Secretary, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts


Search for Jobs